Literature DB >> 3014869

Identification of a beta-thalassemia mutation associated with a novel haplotype of RFLPs.

G F Atweh, B G Forget.   

Abstract

The study of the molecular defects that result in beta-thalassemia in Mediterraneans has uncovered a large number of unique mutations. This information is already being utilized for prenatal diagnosis of pregnancies at risk. Here, we report the definitive identification, by molecular cloning, of the beta-thalassemia mutation associated with a Mediterranean chromosome bearing a novel haplotype of restriction fragment length polymorphisms (RFLPs) in the beta gene cluster that has been previously designated as haplotype X. The thalassemia mutation was identified as a T----C base substitution at IVS-1 position 6, a mutation previously described in association with haplotype VI. We describe the use of the restriction enzyme SfaNI for the detection of this mutation and point out a possible pitfall that should be avoided if such an approach is used for the detection of this mutation, which appears to be a common cause of mild beta+-thalassemia in some populations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014869      PMCID: PMC1684858     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  The molecular basis for the clinical diversity of beta thalassaemia in Cypriots.

Authors:  J S Wainscoat; J M Old; D J Weatherall; S H Orkin
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

5.  Prenatal diagnosis of haemoglobinopathies: A status report.

Authors:  B P Alter
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

6.  The nucleotide sequence of the human beta-globin gene.

Authors:  R M Lawn; A Efstratiadis; C O'Connell; T Maniatis
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

7.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

8.  Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia.

Authors:  G P Tamagnini; M C Lopes; M E Castanheira; J S Wainscoat; W G Wood
Journal:  Br J Haematol       Date:  1983-06       Impact factor: 6.998

9.  Nucleotide sequence analysis of the delta beta-globin gene region in humans.

Authors:  M Poncz; E Schwartz; M Ballantine; S Surrey
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

10.  Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia.

Authors:  C D Boehm; S E Antonarakis; J A Phillips; G Stetten; H H Kazazian
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

View more
  2 in total

1.  Combination of two rare mutations causes β-thalassaemia in a Bangladeshi patient.

Authors:  Mahdi Muhammad Moosa; Mustak Ibn Ayub; Ama Emran Bashar; Golam Sarwardi; Waqar Khan; Haseena Khan; Sabina Yeasmin
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

2.  Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron.

Authors:  J E Metherall; F S Collins; J Pan; S M Weissman; B G Forget
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.